Okay good to know. I was thinking that, like OL, a company would not want to finance another trial (for a different disease) unless they had a stake in the company, or acquired it. But I don't know that's why I'm asking.

Quote:

---

I don’t assume that, rather financial commitment on their end to support the next study.

---